IL33 and neoplasm: Based on these results, it is plausible that IL-33 secreted from stellate cells or CAFs acts on other cells, such as macrophages, that are reported to express ST2L and CXCL3 [7–9, 44], rather than on tumor cells themselves to stimulate the secretion of CXCL3.